No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr19:42433200-42441400 |
Bivalent Enhancer |
ES-UCSF4 Cell Line |
embryonic stem cell
|
2 |
chr19:42433600-42444000 |
Weak transcription |
Right Atrium |
heart
|
3 |
chr19:42437800-42440600 |
Enhancers |
Primary T cells from cord blood |
blood
|
4 |
chr19:42437800-42441200 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
5 |
chr19:42437800-42442600 |
Enhancers |
Primary T helper cells fromperipheralblood |
blood
|
6 |
chr19:42437800-42442600 |
Enhancers |
Primary T killer naive cells fromperipheralblood |
blood
|
7 |
chr19:42438200-42441800 |
Enhancers |
K562 |
blood
|
8 |
chr19:42438400-42440800 |
Enhancers |
Primary T helper naive cells from peripheral blood |
blood
|
9 |
chr19:42438400-42440800 |
Enhancers |
Esophagus |
oesophagus
|
10 |
chr19:42438400-42441400 |
Enhancers |
Primary T helper 17 cells PMA-I stimulated |
--
|
11 |
chr19:42438600-42441000 |
Enhancers |
Primary T helper memory cells from peripheral blood 2 |
blood
|
12 |
chr19:42438800-42441400 |
Bivalent Enhancer |
Stomach Mucosa |
stomach
|
13 |
chr19:42439200-42441200 |
Bivalent Enhancer |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
14 |
chr19:42439200-42441600 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
15 |
chr19:42439400-42440800 |
Bivalent Enhancer |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
16 |
chr19:42439400-42440800 |
Bivalent Enhancer |
GM12878-XiMat |
blood
|
17 |
chr19:42439600-42440600 |
Flanking Bivalent TSS/Enh |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
18 |
chr19:42439600-42440800 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
19 |
chr19:42439600-42441000 |
Bivalent Enhancer |
NHLF |
lung
|
20 |
chr19:42439600-42441200 |
Bivalent Enhancer |
NH-A |
brain
|
21 |
chr19:42439600-42444000 |
Weak transcription |
Spleen |
Spleen
|
22 |
chr19:42439800-42441000 |
Enhancers |
HMEC |
breast
|
23 |
chr19:42439800-42442000 |
Weak transcription |
Primary B cells from cord blood |
blood
|
24 |
chr19:42439800-42443600 |
Weak transcription |
Primary T helper naive cells fromperipheralblood |
blood
|
25 |
chr19:42439800-42443800 |
Weak transcription |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
26 |
chr19:42439800-42444600 |
Weak transcription |
Gastric |
stomach
|
27 |
chr19:42440000-42441200 |
Enhancers |
NHDF-Ad |
bronchial
|
28 |
chr19:42440000-42441200 |
Flanking Active TSS |
Osteobl |
bone
|
29 |
chr19:42440200-42440600 |
Enhancers |
Primary T regulatory cells fromperipheralblood |
blood
|
30 |
chr19:42440200-42440600 |
Bivalent Enhancer |
Cortex derived primary cultured neurospheres |
brain
|
31 |
chr19:42440200-42440600 |
Flanking Bivalent TSS/Enh |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
32 |
chr19:42440200-42440600 |
Flanking Bivalent TSS/Enh |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
33 |
chr19:42440200-42440600 |
Flanking Active TSS |
HSMM |
muscle
|
34 |
chr19:42440200-42440800 |
Flanking Bivalent TSS/Enh |
NHEK |
skin
|
35 |
chr19:42440200-42441000 |
Bivalent Enhancer |
Placenta Amnion |
Placenta Amnion
|
36 |
chr19:42440200-42441000 |
Enhancers |
HSMMtube |
muscle
|
37 |
chr19:42440200-42441200 |
Bivalent Enhancer |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
38 |
chr19:42440200-42441200 |
Enhancers |
A549 |
lung
|
39 |
chr19:42440200-42441400 |
Bivalent Enhancer |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
40 |
chr19:42440400-42440600 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
41 |
chr19:42440400-42440600 |
Enhancers |
Primary T helper cells PMA-I stimulated |
--
|
42 |
chr19:42440400-42440600 |
Bivalent Enhancer |
Primary T killer memory cells from peripheral blood |
blood
|
43 |
chr19:42440400-42440600 |
Flanking Bivalent TSS/Enh |
Muscle Satellite Cultured Cells |
--
|
44 |
chr19:42440400-42440600 |
Bivalent Enhancer |
Colonic Mucosa |
Colon
|
45 |
chr19:42440400-42440800 |
Bivalent Enhancer |
Duodenum Mucosa |
Duodenum
|
46 |
chr19:42440400-42441000 |
Bivalent/Poised TSS |
Rectal Mucosa Donor 29 |
rectum
|
47 |
chr19:42440400-42441200 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
48 |
chr19:42440400-42441200 |
Flanking Active TSS |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
49 |
chr19:42440400-42441600 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
50 |
chr19:42440400-42442600 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|